Galapagos NV
Most Recent
Gilead Sciences Expands Collaboration with Galapagos
On July 14, Gilead Sciences announced that it will expand its collaboration with Galapagos (GLPG).
Company & Industry Overviews What’s behind the Dismal Performance of NBQAX?
NBQAX has had a terrible 2016 so far. Among its top invested sectors, information technology has been almost inconsequential to its performance.
AbbVie Expects to Commercialize Selective JAK1 Inhibitor ABT-494
Currently being tested in six Phase 3 trials, ABT-494 is expected to be a significant improvement in the standard of care for rheumatoid arthritis.
Company & Industry Overviews Why Has the Nuveen International Growth Fund Stumbled in YTD 2016?
Through June 17, the Nuveen International Growth Fund – Class A (NBQAX) has figured among the bottom three funds in its peer group of 12 funds.